Line Plot from Scientific Research

Spider plot showing CT-assessed change in target lesion size from the pre-treatment scan for each patient throughout the study. Certain patients highlight the difficulty in summarizing outcomes using response: = lesions grew during ICI-4W, but eventually attained irPR during immunochemotherapy;*= irCR but average PFS (progressed at 9.3 months); = PFS>12 months but no irRECIST response (two additional cases had non-assessable target lesion sizes).

DOI